Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Haoxi Health TechnologyHAO -13.09%21 EBIT per Share is $910.50 as of Dec. 2025. GuruFocus rates HAO with a GF Score™ of 21/100. The stock has 5 warning signs investors should review. Among 746 Media - Diversified companies, Haoxi Health Technology ranks worse than 134048.12% on this metric.
Haoxi Health Technology's EBIT per Share for the
six
months ended in Dec. 2025 was $-3,257.50.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $910.50.
During the past 12 months, the average EBIT per Share Growth Rate of Haoxi Health Technology was -710.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Haoxi Health Technology's EBIT per Share or its related term are showing as below:
HAO's 3-Year EBIT Growth Rate is not ranked *
in the Media - Diversified industry.
Industry Median: 2.6 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Haoxi Health Technology (NAS:HAO) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Haoxi Health Technology EBIT per Share Related Terms
Haoxi Health Technology EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $910.50
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haoxi Health Technology (HAO) has a EBIT per Share of $910.50 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Haoxi Health Technology and its competitors. According to the industry distribution chart, Haoxi Health Technology ranks #999999 out of 746 companies in the Media - Diversified industry.
Is Haoxi Health Technology's EBIT per Share too high?
Haoxi Health Technology's current EBIT per Share is $910.50. The Media - Diversified industry median EBIT per Share is 2.60. Haoxi Health Technology's value of $910.50 is 34919.2% above this industry median. Based on the distribution chart, Haoxi Health Technology ranks #999999 out of 746 companies in the Media - Diversified industry, which is in the bottom quartile relative to peers. Overall, Haoxi Health Technology has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Haoxi Health Technology's EBIT per Share compare to BAOS and DBMM?
According to the Media - Diversified industry distribution chart, Haoxi Health Technology ranks #999999 out of 746 companies for EBIT per Share. This places Haoxi Health Technology in the lower half of its industry. The industry median EBIT per Share is 2.60. Haoxi Health Technology's value of $910.50 is 34919.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Media - Diversified company?
The median EBIT per Share among Media - Diversified companies is 2.60, based on 746 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haoxi Health Technology's current EBIT per Share of $910.50 is 34919.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Haoxi Health Technology and its competitors. For the Media - Diversified industry, the median EBIT per Share is 2.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haoxi Health Technology's current EBIT per Share is $910.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haoxi Health Technology stock overvalued right now?
Haoxi Health Technology (HAO) has a current EBIT per Share of $910.50. The current EBIT per Share is $910.50 and 34919.2% above the Media - Diversified industry median of 2.60. Haoxi Health Technology's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Haoxi Health Technology (HAO), the current EBIT per Share is $910.50 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. The company offers services that include planning, producing, placing, and optimizing online ads especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms. It places advertisements on popular digital platforms such as Toutiao, Douyin, WeChat, and Sina Weibo through media partners. Revenue is generated by providing comprehensive online marketing solutions. The company's operations center on digital advertising via mainstream video and social media channels in the Chinese market.
21GF Score
Get the complete analysis for HAO
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAO has been successfully added to your 
